期刊
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 105, 期 -, 页码 617-620出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2021.02.087
关键词
COVID-19; Co-infections; Pandemic; SARS-CoV-2; Respiratory co-infections
This study investigated bacterial and viral co-infections in COVID-19 patients and found a lower rate of viral co-infections overall, but significant levels of Staphylococcus aureus and Epstein-Barr virus co-infections in SARS-CoV-2-positive patients. The findings contribute to our understanding of the current pandemic and can assist clinicians in making better patient care decisions.
The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented challenge to our healthcare system. Secondary and concurrent bacterial and viral co-infections are well documented for other viral respiratory pathogens; however knowledge regarding co-infections in COVID-19 remains limited. In the present study, concurrent testing of 50 419 individual samples for the presence of SARS-CoV-2 and other bacterial and viral respiratory pathogens was performed between March and August 2020. Overall, a lower rate of viral co-infection was observed in the SARS-CoV-2-positive population when compared to the population testing negative for the virus. Significant levels of Staphylococcus aureus and Epstein-Barr virus co-infections were detected in the SARS-CoV-2-positive population. This is one of the largest surveys looking into the co-infection patterns of SARS-CoV-2 infection in the United States. Data from this study will enhance our understanding of the current pandemic and will assist clinicians in making better patient care decisions, especially with respect to antimicrobial therapy. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据